[HTML] frontiersin.org

[HTML][HTML] Investigation of correlations between optical coherence tomography biomarkers and visual acuity in X-linked retinoschisis

Z Lin, S Zang, DJA Maman Lawali, Y Xiao… - Frontiers in …, 2022 - frontiersin.org
Purpose: To investigate the imaging biomarkers of spectral-domain optical coherence
tomography (SD-OCT) and their correlations with age and best-corrected visual acuity …
Save Cite Cited by 5 Related articles All 5 versions Cached
[HTML] frontiersin.org

[HTML][HTML] Difference of central foveal thickness measurement in patients with macular edema using optical coherence tomography in different display modes

DJAM Lawali, G Wu, ND Adam, Z Lin, H Kong… - Frontiers in …, 2024 - frontiersin.org
Purpose To assess the differences in the measurement of central foveal thickness (CFT) in
patients with macular edema (ME) between two display modes (1: 1 pixel and 1: 1 micron) …
Save Cite Related articles All 5 versions Cached

Impaired retinal microcirculation in patients with non-obstructive coronary artery disease

Y Ren, Y Hu, C Li, P Zhong, H Liu, H Wang… - Microvascular …, 2023 - Elsevier
Purpose To quantitatively investigate alterations of retinal microcirculation in patients with
non-obstructive coronary artery disease (NOCAD) using optical coherence tomography …
Save Cite Cited by 3 Related articles All 2 versions
[PDF] bmj.com

Association of hyperopia with incident clinically significant depression: epidemiological and genetic evidence in the middle-aged and older population

Z Du, X Zhang, Y Hu, Y Huang, G Bulloch… - British Journal of …, 2023 - bjo.bmj.com
Aims To investigate the association between hyperopia and clinically significant depression
(CSD) in middle-aged and older individuals. The effect of genetic determinants of hyperopia …
Save Cite Related articles All 8 versions

3D Bioprinting in Conjunction with Bone Marrow Mesenchymal Stem Cells for the Treatment of Bone Defects

MI Nasser, Z Han, DJAM Lawali, D Gang… - Handbook of Stem Cell …, 2023 - Springer
Clinical management of bone defects remains a challenge. Currently, the principal
therapeutic option is autologous or synthetic bone grafting. However, bone grafting is not …
Save Cite Related articles